Q2 Earnings Forecast for CareCloud Issued By Zacks Research

CareCloud, Inc. (NASDAQ:CCLD) – Stock analysts at Zacks Research issued their Q2 2026 earnings per share (EPS) estimates for CareCloud in a research report issued to clients and investors on Thursday, March 12th. Zacks Research analyst M. Kim forecasts that the company will earn $0.11 per share for the quarter. The consensus estimate for CareCloud’s current full-year earnings is $0.58 per share. Zacks Research also issued estimates for CareCloud’s Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.45 EPS and FY2027 earnings at $0.53 EPS.

CareCloud (NASDAQ:CCLD) last released its quarterly earnings results on Thursday, March 12th. The company reported $0.11 earnings per share for the quarter, meeting the consensus estimate of $0.11. CareCloud had a net margin of 8.96% and a return on equity of 24.96%. The business had revenue of $34.42 million for the quarter, compared to analysts’ expectations of $32.10 million. CareCloud has set its FY 2026 guidance at 0.200-0.23 EPS.

CCLD has been the topic of several other research reports. Wall Street Zen upgraded shares of CareCloud from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Weiss Ratings restated a “hold (c-)” rating on shares of CareCloud in a report on Monday, December 29th. Finally, ThinkEquity began coverage on CareCloud in a report on Monday, November 24th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, CareCloud currently has a consensus rating of “Hold” and an average target price of $3.25.

CareCloud Trading Up 7.9%

NASDAQ:CCLD opened at $3.14 on Friday. The company has a 50-day moving average price of $2.68 and a 200-day moving average price of $3.06. The stock has a market cap of $133.14 million, a price-to-earnings ratio of 39.25 and a beta of 2.09. The company has a current ratio of 1.26, a quick ratio of 1.24 and a debt-to-equity ratio of 0.12. CareCloud has a 12 month low of $1.14 and a 12 month high of $4.01.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Hillsdale Investment Management Inc. boosted its stake in CareCloud by 20.6% during the fourth quarter. Hillsdale Investment Management Inc. now owns 804,508 shares of the company’s stock worth $2,349,000 after acquiring an additional 137,637 shares in the last quarter. Essex Investment Management Co. LLC bought a new position in shares of CareCloud during the fourth quarter valued at approximately $2,000,000. Renaissance Technologies LLC lifted its holdings in shares of CareCloud by 96.1% during the fourth quarter. Renaissance Technologies LLC now owns 446,030 shares of the company’s stock valued at $1,302,000 after purchasing an additional 218,530 shares during the last quarter. Bridgeway Capital Management LLC lifted its holdings in shares of CareCloud by 18.3% during the fourth quarter. Bridgeway Capital Management LLC now owns 380,823 shares of the company’s stock valued at $1,112,000 after purchasing an additional 58,805 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of CareCloud by 235.4% in the 2nd quarter. Geode Capital Management LLC now owns 359,486 shares of the company’s stock worth $848,000 after purchasing an additional 252,299 shares in the last quarter. 10.16% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about CareCloud

Here are the key news stories impacting CareCloud this week:

• Positive Sentiment: CareCloud reported record net income and its first full-year positive EPS since IPO, said it exceeded revenue guidance, and introduced new generative AI products — a fundamental update that supports growth and margin narrative. Read More.
• Positive Sentiment: Q4 revenue beat consensus ($34.42M vs. $32.10M) and EPS matched estimates at $0.11, signaling revenue momentum even as year-over-year EPS fell; management provided supplemental materials (press release/slide deck) for investors. Read More.
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast (from $0.43 to $0.45) and published updated quarterly/FY2027 estimates, reflecting analyst model adjustments after the results. Read More.
• Neutral Sentiment: Zacks published detailed quarterly estimates (Q2–Q4 2026 and FY2027), which give investors a roadmap for expected cadence but do not materially change consensus yet. Read More.
• Neutral Sentiment: Reported short-interest data in recent feeds shows anomalous “0 shares / NaN” entries; the published short-interest figures appear unreliable and should be treated cautiously. (Data items from March filings showed inconsistent values.)
• Negative Sentiment: CareCloud set FY2026 EPS guidance at $0.20–$0.23, below the consensus (~$0.24), and gave revenue guidance of $128–$132M (vs. consensus ~$130.6M) — the lower EPS range is a headwind that likely tempered some investor enthusiasm. Read More.

About CareCloud

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.